Nontuberculous Mycobacteria: Diagnosis and Therapy

Area of Science:

• Pulmonology
• Infectious Diseases
• Microbiology

Background:

• Bronchiectasis is a significant risk factor for developing nontuberculous mycobacteria (NTM) disease.
• Worsening respiratory symptoms and radiographic progression in bronchiectasis patients warrant high suspicion for NTM infection.

Purpose of the Study:

• To outline diagnostic and therapeutic considerations for nontuberculous mycobacteria (NTM) disease in patients with bronchiectasis.
• To emphasize appropriate management strategies and the importance of individualized treatment decisions.

Main Methods:

• Review of clinical guidelines and evidence regarding NTM disease in bronchiectasis.
• Discussion of diagnostic criteria, treatment principles, and monitoring protocols.

Main Results:

• Diagnosis of NTM disease requires careful clinical assessment beyond meeting case definitions.
• Treatment decisions must weigh patient-specific risks and benefits.
• Effective NTM treatment necessitates multidrug regimens guided by laboratory susceptibility testing.
• Monotherapy and macrolide-fluoroquinolone dual therapy are contraindicated.
• Post-treatment surveillance is crucial due to high relapse rates.

Conclusions:

• Prompt recognition and appropriate management of NTM disease are critical for patients with bronchiectasis.
• Adherence to evidence-based treatment guidelines, including susceptibility-guided multidrug therapy and vigilant follow-up, improves patient outcomes.
• Avoiding suboptimal therapies like monotherapy is essential to prevent treatment failure and resistance.